SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-007568
Filing Date
2023-03-10
Accepted
2023-03-10 16:51:41
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K ovid-20230310.htm   iXBRL 8-K 38130
  Complete submission text file 0001628280-23-007568.txt   178121

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovid-20230310.xsd EX-101.SCH 1896
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovid-20230310_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovid-20230310_pre.xml EX-101.PRE 13042
6 EXTRACTED XBRL INSTANCE DOCUMENT ovid-20230310_htm.xml XML 12315
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 23724426
SIC: 2834 Pharmaceutical Preparations